Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
Amany A. Alzokaky(Damietta University), Samar A. Antar(Damietta University), Mohammed A. S. Abourehab(Umm al-Qura University), Amira E. Farage(Kafrelsheikh University), Ahmed A. Al‐Karmalawy(Damietta University), Mohamed A. Saleh, Walied Abdo(Kafrelsheikh University), Amany Belal(Beni-Suef University)
Cited by 40
Related Papers
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
|Biomedicine & Pharmacotherapy|2023|521
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
|International Journal of Molecular Sciences|2023|337
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
|Pharmaceuticals|2024|101